3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Interventions
Gemcitabine
17
Magnetic Resonance Spectroscopy
16
Specimen Handling
15
Cisplatin
12
pembrolizumab
11
enfortumab vedotin
7
Mitomycin
7
Cystoscopy
7
durvalumab
5
avelumab
5
Transurethral Resection of Bladder
5
Radiation
5
Fluorouracil
5
Carboplatin
5
Biopsy
5
Radiotherapy
4
Nivolumab
4
Cystectomy
4
tremelimumab
3
erdafitinib
3
dehydroftorafur
3
cabozantinib
3
atezolizumab
3
Platinum
3
Mitozytrex
3
Immunoglobulin G
3
Disulfides
3
1,2-diaminocyclohexaneplatinum II citrate
3
ulixertinib
2
sapanisertib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Plasmapheresis
×
30 days
×
Clear all
NCT07087860
2026-05-08
RECIPE-B1
Mayo Clinic
Phase 2
Recruiting
70 enrolled